Is the Patient Getting Worse?

Singh Kuldev*
Glaucoma Service, Stanford University, USA

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 1933
Abstract HTML Views: 1573
PDF Downloads: 576
Total Views/Downloads: 4082
Unique Statistics:

Full-Text HTML Views: 1038
Abstract HTML Views: 918
PDF Downloads: 395
Total Views/Downloads: 2351

Creative Commons License
© Kuldev Singh; Licensee Bentham Open.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.

* Address correspondence to this author at the Glaucoma Service, Stanford University, USA; E-mail:


Glaucoma care today is often simplified into all or nothing terms with the assumption that if the patient’s intraocular pressure (IOP) is above a certain level, glaucomatous disease will progress and when the IOP is lowered to below a threshold, no further progression will occur. This dogma is largely the result of limitations in the resolution of tools currently available to judge progression. Glaucoma is a neurodegenerative disease and, as with all degenerative diseases, progression continues to occur, albeit at slower rates, with appropriate treatment. In the future, as our tools to assess structural and functional optic nerve change become more precise, we will no longer think of glaucoma as being stable or progressive but rather speak in terms of rates of progression.